An improved bioluminescent assay of gentamicin in serum, based on the dose-dependent effect of the agent on the accumulation of extracellular ATP in Escherichia coli LU 14 cultures, is presented. The accuracy of the bioluminescent assay of gentamicin, expressed as the mean coefficient of variation over the therapeutic range, was 2.8%. Corresponding figures for an agar diffusion assay, a latex agglutination inhibition card test, an enzynme immunoassay, and a fluorescence immunoassay were 6.4, 17.5, 4.2, and 9.4%, respectively. All of the methods correlated well (r = 0.926 to 0.976), with the possible exception of the card test (r = 0.777 to 0.841). The bioluminescent assay requires only 1 jd1 of serum, which allows for capillary sampling, and results are available within 75 min.
The firefly bioluminescence assay of bacterial ATP has been used to study the effects of antibiotics on bacteria (4, 9) . In the assay of ATP, conditions are arranged so as to result in a constant light emission proportional to the ATP concentration (3) .
Rapid effects of gentamicin on ATP levels in bacterial cultures have been studied, and bioluminescent assays based on dose-dependent decreases of total ATP (2) and of intracellular ATP (6) have been developed. Both methods require extraction of intracellular ATP. Gehtamicin causes damage to bacteria, which leads to leakage of ATP into the growth medium (4) . The accumulation of extracellular ATP varies with the adenosine triphosphatase activity of the test strain (5, 9) . A dose-dependent accumulation of extracellular ATP was demonstrated in Escherichia coli LU 14 cultures exposed to gentamicin (4) . This phenomenon was used to develop an assay of gentamicin in serum which does not require an extraction procedure (4). E. coli LU 14 provides for a specific bioluminescent assay of gentamicin since it is unaffected by other antibiotics encouhtered in combination with gentamicin (6) . In this report, the extracellular method is improved, simplified, and evaluated by comparison with an agar diffusion assay, a latex agglutination inhibition card test (8) , an enzyme immunoassay (EMIT) (7), and a fluoresence immunoassay (FIA) (1 (Fig. 1) . The relation between extracellular :ate.
ATP and log gentamicin concentrations was most linear after macrovue card 45 min of incubation (Fig. 2) . Shorter incubation times decreased the discriminatory power (i.e., slope), expressed as the light-intensity difference between twofold dilutions of gentamicin, and longer incubation times decreased the slope M i n ut e s of the standard graph at gentamicin concentrations greater than 6 mg/liter (Fig. 2) .
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The accuracy of the agar disk diffusion assay, bioluminescent assay, card test, EMIT, and FIA has been assessed by ,* 60 r=0.976 y=0.97x+0.33 (Fig. 3, 4 , 5, and 6). 
DISCUSSION
This study shows methodological improvements in the bioluminescent assay of gentamicin in serum (5) . The paper disk used in the assay caused a loss of drug activity (10) . The accumulation of extracellular ATP became more rapid and pronounced and took place at lower concentrations after omitting the paper disk. This allowed for dilution of serum samples in Tris buffer, thus preventing any influence of variations of pH in serum samples. The discriminatory power (i.e., slope) was increased, and the incubation time could be decreased from 75 (4) to 45 min.
The evaluation of the assay methods demonstrated that accuracy was acceptable for the agar diffusion assay, bioluminescent assay, EMIT, and FIA (range of CV, 2.8 to 4.4%) and that they correlated well (r = 0.926 to 0.976). A possible exception is the card test, which has a mean CV of 17.6% and an r value of 0.777 to 0.841. This indicates that the bioluminescent assay is comparable to the other methods used.
The turnaround time for the bioluminescent assay is longer than those for the card test, EMIT, and FIA, but the assay result is available before the next dose, permitting a dose adjustment if necessary. The required serum sample is only 1 [l, which allows for capillary sampling. ly one-half year when stored at -18°C or lower. Reconstituted reagent stability is 2 months at -18°C, 24 h at 4°C, and 7 h at 25°C. This fulfills the requirement for optimal use of a kit within the shelf life of the reagent.
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